Search results
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
Zacks· 2 days agoThe Zacks Large Cap Pharmaceuticals industry, to which AbbVie belongs, has lost 1.9% over this period. Now the key question is: Where could the stock be ...
AbbVie earnings beat by $0.04, revenue topped estimates By Investing.com
Investing.com· 7 days agoAbbVie earnings beat by $0.04, revenue topped estimates
AbbVie (NYSE:ABBV) Price Target Cut to $187.00
ETF DAILY NEWS· 2 days agoBarclays‘s target price would suggest a potential upside of 14.94% from the company’s previous close. Several other equities research analysts have also recently commented ...
Why AbbVie Stock Stumbled Today Despite the Earnings Beat
Motley Fool via Yahoo Finance· 6 days agoThe company even upped its full-year profit outlook. But AbbVie stock fell all the same, closing...
Better Dividend Stock: AbbVie or Johnson & Johnson?
Motley Fool via Yahoo Finance· 5 days agoThe Motley Fool has positions in and recommends Abbott Laboratories. The Motley Fool recommends Johnson & Johnson. The Motley Fool has a disclosure...
AbbVie (ABBV) Beats Q1 Earnings and Revenue Estimates
Zacks via Yahoo Finance· 7 days agoAbbVie (ABBV) delivered earnings and revenue surprises of 2.21% and 2.65%, respectively, for the...
Investors Take AbbVie To The Woodshed. But Its Woes Are 'Unfounded.'Investors Take AbbVie To The...
Investor's Business Daily· 3 days agoOn Friday, AbbVie beat first-quarter expectations, largely on the back of its immunology franchise....
AbbVie (NYSE:ABBV) Price Target Cut to $180.00 by Analysts at BMO Capital Markets
ETF DAILY NEWS· 3 days agoA number of other analysts have also recently weighed in on the company. Truist Financial raised their price objective on AbbVie from $180.00 to $195.00 ...
AbbVie (NYSE:ABBV) Shares Down 0.5% After Analyst Downgrade
ETF DAILY NEWS· 2 days agoAbbVie Inc. (NYSE:ABBV – Get Free Report) shares fell 0.5% on Monday after Barclays lowered their price target on the stock from $195.00 ...
BMO cuts Abbvie stock PT on lower revenue outlook for Vraylar, Humira concerns By Investing.com
Investing.com· 4 days agoOn Monday, BMO (TSX:BMO) Capital Markets adjusted its outlook onAbbvie (NYSE:ABBV), a...